To Access the Effects of Mucositis in Adults With Dental Implants

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Clinical research for the treatment of mucositis subjects who have dental implants for a minimum of one-year.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Colgate Palmolive
• Treatments: Fluorides; Triclosan

Criteria

Inclusion Criteria:

• Male and female subjects, ages 30-70.

• Availability for the six-month duration of the clinical research study.

• Good general health.

• Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants.

• Minimum of 5 remaining teeth and a minimum of 2 implants.

• Initial evaluation of the gingival and peri-implant mucosal tissues by determining full mouth bleeding on probing.

• Initial plaque evaluation by determining full mouth presence/absence of plaque.

• Signed Informed Consent Form.

Exclusion Criteria:

• Tumor(s) of the soft or hard tissues of the oral cavity.

• Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone).

• Carious lesions requiring immediate restorative treatment.

• Uncontrolled Diabetes

• Use of antibiotics any time during the one month prior to entry into the study.

• Untreated peri-implantitis.

• Participation in any other clinical research study or test panel within the three months prior to entry into the study.

• Pregnant women or women who are breast feeding.

• History of allergies to personal care/consumer products or their ingredients.

• Medical condition which prohibits not eating/drinking for up to 2 hours.

• Current alcohol or drug abuse.

• Systemic or local disease conditions that would compromise post-operative healing.

• Regular use of anti-inflammatory drugs.